Literature DB >> 6713406

Prognostic significance of nuclear DNA content in serous ovarian tumors.

K Erhardt, G Auer, E Björkholm, G Forsslund, B Moberger, C Sifverswärd, G Wicksell, A Zetterberg.   

Abstract

Specimens from 73 serous ovarian cancers were examined with respect to DNA content of the tumor cells. The prognostic value of DNA analysis, as reflected in patient survival, was retrospectively compared with that of conventional histological assessment of cancer. DNA in individual tumor cells was measured in sections from the original paraffin-embedded specimens. High proportions of cells with very high DNA values were identified in tumors from 16 patients, 10 of whom died of the disease during the follow-up period. The histological classification was invasive adenocarcinoma in 47 tumors and borderline cancer in 26. All of the patients who died had invasive adenocarcinoma. Although both DNA analysis and histological evaluation were sensitive predictors of mortality, the specificity of the DNA method was distinctly higher (0.90 versus 0.42). The study suggests that analysis of the DNA content of tumor cells can be a useful supplement to histological assessment of cancer and accordingly can significantly assist in the planning of treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713406

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  [DNA cytophotometry in pathology and surgery].

Authors:  M Dietel
Journal:  Langenbecks Arch Chir       Date:  1992

2.  Nuclear DNA content of borderline tumors of the ovary: correlation with histology and significance for prognosis.

Authors:  M Dietel; H Arps; A Rohlff; R Bodecker; A Niendorf
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  DNA distribution pattern in intestinal carcinoid tumors.

Authors:  G Cohn; K Erhardt; B Cedermark; B Hamberger; G Auer
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

4.  Nuclear DNA patterns and survival in metastasizing ileal carcinoids.

Authors:  A P Nobin; K Erhardt; G Auer; S Falkmer; H Mårtensson
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

5.  Assessment of malignancy potential in so-called interval mammary carcinomas.

Authors:  A von Rosen; K Erhardt; L Hellström; A Somell; G Auer
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications.

Authors:  Manohar Pradhan; Ben Davidson; Claes Göran Tropé; Håvard Emil Danielsen; Vera Maria Abeler; Björn Risberg
Journal:  Virchows Arch       Date:  2009-05-08       Impact factor: 4.064

7.  DNA cytophotometry in malignant thyroid tumors--use of different evaluation schemes for prognostic statements.

Authors:  H Arps; B Sablotny; M Dietel; A Niendorf; S Schröder
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

8.  Morphometric, DNA and PCNA in thin malignant melanomas.

Authors:  V Björnhagen; E Månsson-Brahme; J Lindholm; A Mattsson; G Auer
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

9.  Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies.

Authors:  J Akahira; T Inoue; T Suzuki; K Ito; R Konno; S Sato; T Moriya; K Okamura; A Yajima; H Sasano
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients.

Authors:  J P Baak; N W Schipper; E C Wisse-Brekelmans; T Ceelen; F T Bosman; H van Geuns; J Wils
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.